Stocksigma LogoStocksigma Logo

Orchid Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 34,127 (+14.3% YoY | +12.2% QoQ) ■ EBITDA: 2,414 (+682.6% YoY | +72.4% QoQ) ■ EBITDA Margin (%): 7.1 (+604 bps YoY | +247 bps QoQ) ■ PAT: 2,859

Orchid Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Orchid Pharma Ltd · Outcome · 14 Nov 2026, 9:45 pm

Orchid Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 34,127 (+14.3% YoY | +12.2% QoQ) ■ EBITDA: 2,414 (+682.6% YoY | +72.4% QoQ) ■ EBITDA Margin (%): 7.1 (+604 bps YoY | +247 bps QoQ) ■ PAT: 2,859 (Loss to Profit YoY | +786.8% QoQ) ■ EPS (INR): 4.77 (Loss to Profit YoY | +783.3% QoQ)

Original exchange filing (PDF)

More announcements from Orchid Pharma Ltd

All Orchid Pharma Ltd announcements